The RDAF publishes the report from its workshop on post-marketing registries

    8 Nov, 2023

    The report from the RDAF multi-stakeholder workshop on post-marketing registries for rare diseases, which took place on 21 September 2023 in Basel, is now available.

    The workshop fostered an inclusive dialogue between academia, healthcare professionals, industry, patient representatives and digital health organizations that helped develop a mutual understanding on the main challenges and debate on solutions for action. Attendees delved into a range of topics related to post marketing registries for rare diseases, including stakeholders’ role and involvement, goal definition, governance, funding and data collection and (re)use.

    Read the full report to find out more about the discussion outcomes.

    Continue reading

    Boehringer Ingelheim joins the Rare Disease Action Forum

    We are delighted to announce Boehringer Ingelheim as new member of the Rare Disease Action Forum. Boehringer Ingelheim’s membership fortifies RDAF's multi-stakeholder base, alongside other members from industry, patient organizations, healthcare professionals, and...